Wash U Study Highlights Power of Sequencing Patient Tumors in Breast Cancer Clinical Trial | GenomeWeb

By Monica Heger

This story was originally published on August 6

Using patient samples
from an ongoing clinical trial of hormone therapy in breast cancer, researchers from Washington University's Genome Center have sequenced 50 tumor/normal pairs from breast cancer patients with the goal of identifying genomic signatures in the patients who respond to the therapy as well as in those who did not respond.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.